Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 2 minute read Pharma Industry News Cell therapy company Talaris Therapeutics raises $100m in Series A round Talaris Therapeutics (formerly Regenerex) has raised $100 million in a Series A financing round to advance its allogeneic… bypharmanewsdailyMay 25, 2019